Beijing, China

Yaping Gao



Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2021

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Yaping Gao: Innovator in Chemosynthetic Peptides

Introduction

Yaping Gao is a notable inventor based in Beijing, China. She has made significant contributions to the field of biochemistry, particularly in the development of chemosynthetic peptides. Her work focuses on innovative solutions for inhibiting toxins, which has important implications in the pharmaceutical industry.

Latest Patents

Yaping Gao holds a patent for a "Chemosynthetic cyclo-hepta modified peptide capable of inhibiting toxin and use thereof." This invention relates to a chemosynthetic cyclo-hepta modified peptide that can specifically inhibit the production of toxins through the binding of the RNAIII activator protein via autocrine mechanisms. The general formula of the chemosynthetic cyclo-hepta modified peptide is CH—(CH)m-X-G-(CQHWWHWYC)—(R)n-Y. The results indicate that this modified peptide is well-soluble in water and exhibits good activity against certain toxins.

Career Highlights

Throughout her career, Yaping Gao has worked with various companies, including Zhongcheng Investment Management (Shanghai) Co., Ltd and Applied Nanosystems B.V. Her experience in these organizations has contributed to her expertise in the field of biochemistry and peptide synthesis.

Collaborations

Yaping Gao has collaborated with notable professionals in her field, including Ningsheng Shao and Guang Yang. These collaborations have further enhanced her research and development efforts in chemosynthetic peptides.

Conclusion

Yaping Gao's innovative work in the development of chemosynthetic peptides represents a significant advancement in the fight against toxins. Her contributions to the pharmaceutical field highlight the importance of research and innovation in improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…